Buy Ebixa 10 mg 100 Tablets Online Memantine Hydrochloride
Ebixa (Memantine) is a type of medicine that has been approved for the treatment of patients with moderate to severe Alzheimer's disease. Ebixa does not treat the cause of the disease, but it allows patients maybe some longer function independently.
Memantine (1-amino-3 ,5-dimethyladamantaan) is a derivative of amantadine; it has two additional methyl groups, in comparison with amantadine. The agent was originally proposed as suitable for the treatment of Parkinson's disease, such as amantadine.
Memantine is not protected by a patent. It is sold by several companies, including the brand names Ebixa, and Axura, or as a generic versions of memantine. The products usually contain the hydrochloride salt of memantine.
There are indications that diseases of the brain such as Alzheimer's disease are characterized by a chronic over-stimulation of neuronal NMDA receptors by the neurotransmitter glutamate. This over-stimulation could lead to the damage or death of neurons. Memantine is an NMDA receptor antagonist of these receptors is blocked. It relieves as the symptoms of Alzheimer's disease. The therapeutic effect is small, but memantine is the only drug that in moderate to severe form of Alzheimer's disease has any effect, and that, moreover, does not cause serious side effects (donepezil, rivastigmine and galantamine are used for the treatment of mild -to-moderate alzheimer's disease).